Skip to main content

Table 1 Comparison of general data between two groups of patients [case(%)]

From: Assessment of safety during hospitalization for patients undergoing Surgery after neoadjuvant therapy for moderately advanced Esophageal cancer

Parameter

Experimental group

Control group

P-value

 

(n = 34)

(n = 32)

 

Sex

  

0.240

Male

31

26

 

Female

3

6

 

Age

62.7(49–74)

65.9(51–82)

0.090

Tumor location(%)

  

0.738

Upper

4(11.8)

2(6.3)

 

Middle

16(47.1)

16(50.0)

 

Lower

14(41.1)

14(43.7)

 

Pathological staging

  

0.378

IIIA

7(20.6)

4(12.5)

 

IIIB

27(79.4)

28(87.5)